Walgreens Boots Alliance, which is being taken private by Sycamore Partners, beat analysts' estimates for third-quarter profit on Thursday, helped by cost-cutting measures such as store closures. The ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Investing.com - Walgreens Boots Alliance (NASDAQ:WBA) posted third-quarter earnings and sales that topped estimates, as cost savings helped to offset front-end sales at the likely soon-to-be private ...

Shareholders for Walgreens Boots Alliance overwhelmingly voted to approve the company’s sale to Sycamore Partners, with 96% of shareholders at a special meeting voting to green-light the merger, ...

Walgreens Boots Alliance shareholders approved the company’s sale to private equity firm Sycamore Partners at a July 11 special meeting. Walgreens announced in March that it had entered into a $10 ...

Walgreens reported a 7% jump in sales to reach $39 billion in its fiscal third quarter, reflecting sales growth in its U.S. retail pharmacy and international segments as well as improvements in ...

The deal, announced on March 6, would allow Sycamore Partners to take Walgreens private. The drug-store chain expects the transaction to close in the third or fourth quarter of 2025.

Shareholders of Boots owner Walgreens have agreed to be taken over by American private equity firm Sycamore Partners.

News that Walgreens Boots Alliance quarterly loss was better than expected and pharmacy sales are rising bodes well for a financial turnaround under new private equity ownership. Under future ...

Walgreens Boots Alliance shareholders have approved the company’s $10 billion acquisition by private equity firm Sycamore Partners during a special meeting held July 11. Here are four more notes to ...